• Text size
  • Send this article to a friend
  • Print this article

Drug body backs dual head and neck cancer treatment

A DRUG treatment given the go-ahead yesterday could help save the lives of head and neck cancer patients, doctors said. Taxotere, used to treat sufferers from the aggressive cancer, has been recommended for use by the Scottish Medicines Consortium (SMC).

A DRUG treatment given the go-ahead yesterday could help save the lives of head and neck cancer patients, doctors said.

Taxotere, used to treat sufferers from the aggressive cancer, has been recommended for use by the Scottish Medicines Consortium (SMC).